Navigation Links
BD Announces Results for Third Fiscal Quarter
Date:7/24/2008

p> Ophthalmic Systems 6,170 6,378 (3.3)

TOTAL $401,918 $385,546 4.2

BD DIAGNOSTICS

Preanalytical

Systems $144,416 $139,572 3.5

Diagnostic Systems 135,702 133,374 1.7

TOTAL $280,118 $272,946 2.6

BD BIOSCIENCES

Cell Analysis (1) $80,186 $71,686 11.9

Discovery Labware 36,053 37,907 (4.9)

TOTAL $116,239 $109,593 6.1

TOTAL UNITED STATES $798,275 $768,085 3.9

(1) Cell Analysis consists of the Immunocytometry Systems and the

Pharmingen units that were previously reported separately.

BECTON DICKINSON AND COMPANY

SUPPLEMENTAL REVENUE INFORMATION

REVENUES BY BUSINESS SEGMENTS AND UNITS

Three Months Ended June 30, (continued)

(Unaudited; Amounts in thousands)

International

% Change

FX FX

2008 2007 Reported Neutral Impact

BD MEDICAL

Medical Surgical

Systems $272,064 $233,835 16.3 6.1 10.2

Diabetes Care 97,298 82,754 17.6 4.8 12.8

Pharmaceutical

Systems 230,346 168,057 37.1 19.6 17.5

Ophthalmic Systems 14,770 11,794 25.2 12.6 12.6

TOTAL $614,478 $496,440 23.8 10.6 13.2

BD DIAGNOSTICS

Preanalytical

Systems $146,345 $121,761 20.2 7.5 12.7

Diagnostic Systems 126,959 96,818 31.1 18.4 12.7

TOTAL $273,304 $218,579
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Gerbig Engineering Announces Availability of Cleanroom Utility Panel
2. The Palomino Group Announces Launch of Meeting Support Services Business Unit
3. Misys Announces Preliminary Results for the Year Ended 31 May 2008
4. Cardiome Announces Preferred Share Financing
5. Mercy Health Plans Announces New Name for Their Medicare Advantage Plans: Mercy Medicare Advantage
6. American Heart Associations Announces Call for Entries for Howard L. Lewis Achievement Award
7. The Risk Management and Patient Safety Institute Announces 2008/2009 Annual Risk Management Conference, Dates
8. Genesis Pharmaceuticals Announces New Board Member and Forms Committees
9. Fitness Equipment Retailer Fitness 4 Home Superstore Announces New Scottsdale Location
10. Fidelity National Financial, Inc. Announces Opening of Fidelity National Title de Mexico S.A. de C.V.
11. CIHR announces $4.4 million to improve mental health of Canadians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)..., N.C., Jan. 8 Many companies are ... unstable economic environment. More than,ever wi...lity to manage its,biggest asset -- customers. To...s, marketers must master many fronts: creating eff...aint management, applying savvy market,segmentati...
(Date:1/8/2009)... prolongs lives of key vision cells in mice , ...rchers working with mice have identified a protein...s in both healthy and diseased eyes. , The disc...prevent blindness among people genetically predisp...id. , The protein, known as histone deacetylase...
(Date:1/8/2009)... 8 Physicians Practice and St. Mary... area physicians and their staff more time to devo...ue program designed to help doctors in the Long Be... time-consuming issues of managing a busy practice...er will use Physicians Practice,s extensive resour...
(Date:1/8/2009)...searchers at Oregon Health & Science University,s ...overed that the nerve cells controlling heart rate... be critically important for proper nervous system...ant role in the prevention of Sudden Infant Death ... to the National Institutes of Health, SIDS is the...
Breaking Medicine News(10 mins):Health News:Marketers Share Customer-Centric Strategies for an Uncertain 2009 Economy, Feb 2-4 2Health News:Protein Might One Day Prevent Blindness 2Health News:Protein Might One Day Prevent Blindness 3Health News:Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA 2Health News:Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA 3Health News:OHSU School of Dentistry team discovers new molecule in blood-pressure control system 2
...eye disease targeting the light-collecting cells o...e and can cause // vision loss. Researchers say fo...e addition of docosahexaenoic acid to vitamin A th..., according to a recent study. Researchers followe...
...rapy improves survival and reduces the risk of rec...ancer that has not spread beyond the ovary). About...le confined to the ovaries, when five-year surviva... not to offer chemotherapy for their patients, sin...
...in, or HA1c, may be an independent risk factor for...nd stroke, according to the new research. Two new ...trol and the development of heart disease and stro...000 people, investigators found a 21-percent incre...
...on of alcohol may cut the rate of reblockage follo...rs evaluated 225 men after they had undergone a pe...), a procedure to open blocked arteries with a ste...pens the artery but may cause inflammation resulti...
Other Medicine News:
(Date:1/7/2009)...ERICK, Md., Jan. 7 ImQuest Life Sc...f an IND application to the Food and Drug Administ... lead pyrimidinedione HIV inhibitor IQP-0410. ImQu...n the first quarter of 2009. IQP-0410 is a novel s...s as a nonnucleoside reverse transcriptase inhibit...
(Date:1/6/2009)...ram Expands on Successful Results from prior U.S.,...RNewswire/ -- Vital Therapies, Inc. (VTI), a devel...y announced patient enrollment has begun for a ran...l trial that will study the Extracorporeal Liver A...th Acute Liver Failure (ALF) under three protocols...
(Date:1/6/2009)...VILLE, Md., Jan. 6 Sequ...pany focused on diseases of epidemic potential, an...for the treatment of tuberculosis (TB), was the fi...d clinical program contract to Dynport Vaccine Com..., awarded by the National Institute of Allergy and...
(Date:1/5/2009)...DIEGO, Jan. 5 Cylene Pharmaceutica... clinical trial of its oral CK2 protein kinase inh...umors, Castleman,s disease, or multiple myeloma. T...rial are determination of safety, tolerance and PK...te dose for Phase II trials. In addition, multiple...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3New Therapies Could Change Organ Transplants 9981 1New Therapies Could Change Organ Transplants 9981 2New Therapies Could Change Organ Transplants 9981 3Co Pays Contribute to Drop in Preventive Care 9979 1Co Pays Contribute to Drop in Preventive Care 9979 2Co Pays Contribute to Drop in Preventive Care 9979 3Synthesis of natural molecule could lead to better anti cancer drugs 9977 1Synthesis of natural molecule could lead to better anti cancer drugs 9977 2Synthesis of natural molecule could lead to better anti cancer drugs 9977 3Synthesis of natural molecule could lead to better anti cancer drugs 9977 4Advanced Therapy Aids Stroke Patients 9975 1Advanced Therapy Aids Stroke Patients 9975 2Advanced Therapy Aids Stroke Patients 9975 3
...blished in Journal of Cell Science Shows ONCONASE ...ELD, N.J., April 05, 2007 /PRNewswire-FirstCall/ -...an researchers have,identified the pathway that ON...ished in the Journal of Cell Science (2007; 120: 1...he University of Girona in,Spain and the Universit...
...T, N.J., April 5, 2007-- Stent thrombosis,resteno...ts have,discovered that the drug-coated stents use...more of a detrimental effect on their,health than ...ecent,articles in medical journals suggest that un...inue to take blood thinners, they,could more than ...
Other Medicine Technology:Researchers Identify Intracellular Pathway of Alfacell's Onconase 2Researchers Identify Intracellular Pathway of Alfacell's Onconase 3New Cardioprotective Drug Could Provide Boost For Post-Bypass,Surgery Heart Health 2
Double-ended. 5 mm x 7 mm tips. Designated most popular model or size.
Designated most popular model or size. 4 mm wide tip.
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size.
Double-ended. Semi sharp. Curved 3 mm tips. Angled right and left.
Medicine Products: